Population‐Based Assessment of Cardiometabolic Late Effects in 5‐Year Survivors of Pediatric Acute Lymphoblastic Leukemia
- 28 October 2026
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- p. e70747
Abstract
Introduction: Survival rates for pediatric acute lymphoblastic leukemia (ALL) have improved substantially, shifting attention toward long‐term health. Epidemiologic data on survivors of pediatric ALL from large, population‐based cohorts, particularly in early survivorship, is limited. We addressed this gap by examining the prevalence of diagnosed cardiometabolic conditions among pediatric ALL survivors compared with matched cancer‐free peers during the fifth year after diagnosis. Methods: We conducted a retrospective cohort study using linked data from the Arkansas Central Cancer Registry (2013–2020) and Arkansas All‐Payer Claims Database (2017–2024). Individuals diagnosed with ALL before age 25 years who survived to the fifth year after diagnosis were identified. We matched ALL survivors with three cancer‐free peers by exact matching on sex, race, ethnicity, birth year, Medicaid enrollment history, and county of residence. Cardiometabolic outcomes were identified using claims‐based diagnoses among the ALL survivors and matched controls. We examined differences in cardiometabolic outcomes between ALL survivors and matched controls. Results: ALL survivors ( n = 142; age range 4–30 years) experienced a significantly higher burden of cardiometabolic conditions compared with matched controls ( n = 426; 10.6% vs. 1.2%, p < 0.01). ALL survivors had higher prevalence of hypertension (4.9% vs. 0.9%; p < 0.01) and diabetes mellitus (4.9% vs. 0.2%; p < 0.01). Differences were more pronounced among ALL survivors aged ≥ 14 years, among whom 20.4% (vs. 2.0%; p < 0.01) had at least one cardiometabolic condition. Conclusions: Pediatric ALL survivors experience elevated cardiometabolic risk as early as five years after diagnosis, particularly during adolescence. Early screening and preventive strategies are needed to reduce long‐term cardiometabolic burden among pediatric ALL survivors.Keywords
This publication has 21 references indexed in Scilit:
- Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR StudyPediatric Blood & Cancer, 2025
- Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 studyCancer, 2025
- Investigating the coverage of the Arkansas All-Payer Claims Database for examining health disparities related to persistent poverty areas in colorectal cancer patientsCancer Causes & Control, 2024
- Mortality After Major Cardiovascular Events in Survivors of Childhood CancerJACC, 2024
- Clinical Care for People Who Survive Childhood CancerJAMA, 2023
- Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort StudyCancer, 2019
- The Validity of Using Health Administrative Data To Identify the Involvement of Specialized Pediatric Palliative Care Teams in Children with Cancer in Ontario, CanadaJournal of Palliative Medicine, 2017
- Validity of Health Administrative Database Definitions for Hypertension: A Systematic ReviewCanadian Journal of Cardiology, 2017
- Chronic Health Conditions in Adult Survivors of Childhood CancerOncology Times, 2007
- Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemiaCancer, 2006